http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1082433-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f72e896782207f2ed272d3bd2ecb295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4659af5316b2291f217b139aa04ad3a1 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
filingDate | 1981-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1984-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d681b18a8fcbf911498725b637b74bda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe4585146717c98bca0ec85873590cce |
publicationDate | 1984-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SU-1082433-A1 |
titleOfInvention | Method of prophylaxis of male impotence caused by general and local irradiation of the organism |
abstract | A method for the prevention of male impotence, caused by a general or local irradiation of the organism, by means of drug therapy, in order to lengthen the time of preventive action and eliminate complications, 10-25 days before radiation exposure of the body, the periods of preventive action and elimination of complications can be affected by the body, in the period 10-25 days before radiation exposure of the body, the body should be prolonged and the complications should be eliminated. Injected with a dose of 50-80 krad of autologous blood irradiated in an amount of 3-5% of the total blood volume. |
priorityDate | 1981-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410444203 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3588431 |
Total number of triples: 15.